Emerging Health IssuesFDAMedical Technology

Online Coronavirus Tests Are Just The Latest Iffy Products Marketed To Anxious Consumers

(By Victoria Knight for Kaiser Health News)

Companies with experience in the “at-home” testing market began announcing in mid-March that they would be offering direct-to-consumer test kits for COVID-19.

With panic running high and tests at hospitals and doctors’ offices hard to come by, the appeal was obvious.

The kits were touted as a way for consumers to manage this difficult situation themselves. No struggle to see the doctor. No calls to the health department. No waiting in line at a drive-thru test site. Instead, consumers could collect their own samples, by either swabbing the throat or cheek or spitting into a cup. The samples would then be mailed back to the companies’ partner laboratories, which would test for the coronavirus. Prices ranged from $135 to $181.  Continue reading article here…

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply